New hope for advanced kidney cancer: first human trial of NEO-811 begins
NCT ID NCT07300241
First seen Jan 11, 2026 · Last updated May 17, 2026 · Updated 19 times
Summary
This early-phase study tests a new drug called NEO-811 in about 30 people with advanced clear cell kidney cancer that cannot be removed by surgery. The main goals are to find a safe dose and check for side effects. Participants must have tried or refused standard treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NEO-811 Dallas Site
RECRUITINGDallas, Texas, 75039, United States
-
NEO-811 Grand Rapids Site
RECRUITINGGrand Rapids, Michigan, 49503, United States
-
NEO-811 Houston Site
RECRUITINGHouston, Texas, 77054, United States
-
NEO-811 Long Island Site
RECRUITINGLake Success, New York, 11042, United States
-
NEO-811 South Carolina Site
RECRUITINGMyrtle Beach, South Carolina, 29572, United States
-
NEO-811 Virginia Site
RECRUITINGFairfax, Virginia, 22031, United States
-
NEO-811-101 NYC Site
RECRUITINGNew York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.